CA
INSIDER · TNGX · Tango Therapeutics, Inc. · PRESIDENT, R&D
Crystal Adam
Every open-market transaction filed under this name, Sep 1 to Oct 1.
Filings
3
0 buys · 3 sells
Bought
—
open market, at cost
Sold
$1.3M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Oct 1 | TNGX | Tango Therapeutics, Inc. | President, R&D | Sell | 600 | $25.32 | $15K | — |
| Oct 1 | TNGX | Tango Therapeutics, Inc. | President, R&D | Sell | 26,400 | $24.45 | $646K | — |
| Sep 1 | TNGX | Tango Therapeutics, Inc. | President, R&D | Sell | 27,000 | $22.37 | $604K | — |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.